Jacobs Levy Equity Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$64.5M Sell
911,766
-110,452
-11% -$8.27M 0.27% 96
2025
Q4
$80.7M Buy
1,022,218
+66,843
+7% +$5.29M 0.31% 86
2025
Q3
$78.7M Buy
955,375
+2,700
+0.3% +$212K 0.31% 77
2025
Q2
$76.6M Sell
952,675
-6,192
-0.6% -$478K 0.3% 79
2025
Q1
$77M Buy
958,867
+33,994
+4% +$2.83M 0.31% 79
2024
Q4
$75.7M Sell
924,873
-23,350
-2% -$1.94M 0.27% 92
2024
Q3
$78.2M Buy
948,223
+682,333
+257% +$51M 0.3% 87
2024
Q2
$18.7M Buy
265,890
+127,777
+93% +$9.12M 0.08% 234
2024
Q1
$10.2M Buy
138,113
+6,577
+5% +$458K 0.05% 296
2023
Q4
$8.7M Buy
131,536
+56,478
+75% +$3.53M 0.04% 319
2023
Q3
$4.72M Buy
75,058
+70,558
+1,568% +$4.39M 0.03% 388
2023
Q2
$254K Sell
4,500
-81,010
-95% -$4.5M ﹤0.01% 904
2023
Q1
$4.95M Buy
85,510
+82,179
+2,467% +$5.55M 0.03% 399
2022
Q4
$241K Sell
3,331
-125,881
-97% -$9.02M ﹤0.01% 885
2022
Q3
$7.85M Sell
129,212
-597,429
-82% -$38.2M 0.06% 304
2022
Q2
$45.6M Sell
726,641
-48,137
-6% -$3.19M 0.35% 68
2022
Q1
$54.5M Buy
774,778
+126,101
+19% +$8.53M 0.37% 64
2021
Q4
$40.5M Buy
648,677
+174,862
+37% +$11M 0.27% 95
2021
Q3
$29.2M Buy
473,815
+433,209
+1,067% +$26.1M 0.2% 133
2021
Q2
$2.43M Buy
40,606
+33,565
+477% +$2.13M 0.02% 559
2021
Q1
$428K Sell
7,041
-453,088
-98% -$25M ﹤0.01% 880
2020
Q4
$21.6M Sell
460,129
-644,733
-58% -$27.9M 0.19% 131
2020
Q3
$41.1M Buy
1,104,862
+194,560
+21% +$7.38M 0.43% 53
2020
Q2
$33.2M Buy
910,302
+727,834
+399% +$25.3M 0.36% 68
2020
Q1
$5.58M Buy
182,468
+99,598
+120% +$4.42M 0.07% 271
2019
Q4
$4.22M Buy
+82,870
New +$4M 0.04% 407
2018
Q4
Sell
-316,100
Closed -$14.8M 1035
2018
Q3
$14.8M Sell
316,100
-28,900
-8% -$1.32M 0.21% 131
2018
Q2
$15M Buy
345,000
+258,130
+297% +$12M 0.24% 127
2018
Q1
$3.99M Buy
86,870
+57,090
+192% +$2.77M 0.07% 321
2017
Q4
$1.51M Buy
29,780
+8,770
+42% +$462K 0.03% 524
2017
Q3
$1.09M Sell
21,010
-85,872
-80% -$4.18M 0.02% 572
2017
Q2
$5.23M Buy
106,882
+8,370
+8% +$388K 0.11% 230
2017
Q1
$4.64M Sell
98,512
-359,645
-78% -$17.1M 0.09% 264
2016
Q4
$22M Sell
458,157
-25,914
-5% -$1.19M 0.42% 62
2016
Q3
$19.2M Buy
484,071
+42,479
+10% +$1.6M 0.34% 83
2016
Q2
$15.7M Buy
+441,592
New +$17.2M 0.32% 79
2015
Q4
Sell
-46,608
Closed -$1.96M 856
2015
Q3
$1.96M Sell
46,608
-22,137
-32% -$1.03M 0.04% 362
2015
Q2
$3.43M Sell
68,745
-976
-1% -$46.2K 0.07% 278
2015
Q1
$3.14M Buy
+69,721
New +$3.13M 0.05% 299
2014
Q1
Sell
-26,367
Closed -$1.27M 960
2013
Q4
$1.27M Sell
26,367
-51,275
-66% -$2.3M 0.02% 512
2013
Q3
$3.25M Sell
77,642
-171,913
-69% -$7.41M 0.06% 349
2013
Q2
$10.2M Buy
+249,555
New +$9.18M 0.18% 163

Other funds holding MET

Jacobs Levy Equity Management's MET Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its MetLife (MET) stake by 11% in Q1 2026, selling an estimated $8.27M and leaving 911,766 shares worth $64.5M. The position accounts for 0.27% of the portfolio, ranked #96.

Jacobs Levy Equity Management first reported a position in MET in Q2 2013 and has held it in 42 quarters since. The position peaked at $80.7M in Q4 2025. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Jacobs Levy Equity Management held 911,766 shares of MetLife worth $64.5M as of Q1 2026.
  • Jacobs Levy Equity Management sold 110,452 MetLife shares in Q1 2026, an estimated $8.27M.
  • MetLife made up 0.27% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #96 holding.
  • Jacobs Levy Equity Management first reported a position in MetLife in Q2 2013 and has held it in 42 quarters since.
  • Jacobs Levy Equity Management's MetLife position peaked at $80.7M in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.